Axon Enterprise, INC Form 4 insider transactions

Axon Enterprise's COO and CFO, Brittany Bagley, reported the sale of 2,500 shares of common stock at $610 per share.

Axon Enterprise CEO Patrick W. Smith disposed of 9,096 shares of common stock on November 7, 2025, through a pre-arranged Rule 10b5-1 trading plan.

Axon Enterprise's Chief Revenue Officer, Cameron Brooks, reported the vesting of performance-based restricted stock units and subsequent tax-related share disposition.

AXON Enterprise CEO Patrick W. Smith sold 9,640 shares of common stock on October 7, 2025, through a pre-arranged Rule 10b5-1 trading plan.

Axon Enterprise's COO and CFO, Brittany Bagley, reported the sale of 4,900 common shares and a tax-related disposition of 14,430 shares, primarily executed under a Rule 10b5-1 trading plan.

AXON's Chief Accounting Officer, Jennifer H. Mak, sold 77 shares of common stock for $760 per share on September 15, 2025, under a pre-arranged 10b5-1 trading plan.

AXON Enterprise's COO and CFO, Brittany Bagley, sold 870 shares of common stock for approximately $773.25 per share under a pre-arranged trading plan.

AXON Enterprise Director Jeri Williams sold 100 shares of common stock for a weighted average price of $752.5434 on September 11, 2025, as part of a pre-arranged Rule 10b5-1 plan.

Axon Enterprise CEO Patrick W. Smith sold 10,500 shares of common stock for approximately $7.8 million through a pre-arranged Rule 10b5-1 trading plan.

Axon Enterprise Director Hadi Partovi received a grant of 100 restricted stock units, fully vested, with a transaction date of August 29, 2025.

Axon Enterprise's Chief Revenue Officer, Cameron Brooks, reported a planned disposition of 749 shares of common stock on September 2, 2025, to cover tax liabilities from restricted stock unit vesting.

Axon Enterprise, Inc. Director Jeri Williams received a grant of 100 restricted stock units, which vested immediately, as reported in a recent SEC Form 4 filing.

Axon Enterprise's Chief Accounting Officer, Jennifer Mak, reported the disposition of 160 shares of common stock, including shares for tax liabilities and under a 10b5-1 plan.

Axon Enterprise, Inc. Director Todd Morgenfeld was granted 336 time-vested restricted stock units, set to vest starting August 2026.

Axon Enterprise's COO and CFO, Brittany Bagley, disposed of 815 common shares to cover tax liabilities from restricted stock unit vesting.

Axon Enterprise's Chief Product and Technology Officer, Jeffrey C. Kunins, sold over 7,800 shares of common stock and had shares withheld for taxes, all under a pre-arranged trading plan.

Axon Enterprise President Joshua Isner sold over 23,000 shares of common stock, primarily through a pre-arranged 10b5-1 trading plan and for tax obligations.

Axon Enterprise Director Hadi Partovi acquired 1,358 shares of common stock for approximately $1 million, increasing his beneficial ownership.

Axon Enterprise CEO Patrick W. Smith sold 9,000 shares of common stock on August 11, 2025, through a pre-arranged Rule 10b5-1 trading plan.

Axon Enterprise President Joshua Isner sold 2,500 shares of common stock for approximately $2.18 million under a pre-arranged trading plan.

Axon Enterprise Director Caitlin Kalinowski sold 580 shares of common stock for approximately $505,000 through pre-arranged trading plans.

Axon Enterprise's Chief Operating Officer and Chief Financial Officer, Brittany Bagley, disposed of 1,250 shares of common stock valued at approximately $1 million to cover tax liabilities from restricted stock unit vesting.

Axon Enterprise, Inc. President Joshua Isner reported the disposition of 1,585 shares of common stock through tax withholding and a pre-arranged 10b5-1 trading plan.

Axon Enterprise's Chief Accounting Officer, Jennifer H. Mak, sold 75 shares of common stock for $771.81 per share on June 13, 2025, as part of a pre-arranged Rule 10b5-1 trading plan.

Axon Enterprise's Chief Accounting Officer, Jennifer H. Mak, disposed of 2,150 shares of common stock on June 2, 2025, primarily to cover tax obligations arising from the vesting of restricted stock units.

Axon Enterprise, Inc. Director Michael Garnreiter reported the sale of 6,000 shares of common stock and a charitable gift of 1,000 shares, reducing his beneficial ownership to 17,740 shares.

Axon Enterprise, Inc.'s Chief Operating Officer and Chief Financial Officer, Brittany Bagley, reported a disposition of 15,876 shares of common stock to cover tax liabilities arising from the vesting of restricted stock units.

Axon Enterprise, Inc. President Joshua Isner disposed of 28,489 shares of common stock on June 2, 2025, valued at $758.57 per share, to satisfy tax obligations related to the vesting of restricted stock units.

Jeffrey C. Kunins, Chief Product Officer and Chief Technology Officer of Axon Enterprise, Inc., disposed of 7,928 shares of common stock to satisfy tax liabilities related to the vesting of restricted stock units.

Axon Enterprise's Chief Revenue Officer, Cameron Brooks, sold 3,000 shares of common stock for approximately $2.22 million under a pre-arranged Rule 10b5-1 trading plan.